David Bonita Insider Profile
11 Followers
David Bonita, Director at ImageneBio, holds 1.65M shares in Prelude Therapeutics (Ticker: PRLD), holds 773.75K shares in ImageneBio (Ticker: IMA), holds 20.82K shares in Acutus Medical (Ticker: AFIB). Most recently, David Bonita Bought ― shares of Prelude Therapeutics on Apr 23, 2026 for an estimated value of $12.50M.
David Bonita's Trading History
| PRLDPrelude Therapeutics | Apr 23, 2026 | Director, Ten Percent Owner | Informative Buy | 12.50M | $5.49M | |
| IMAImageneBio | Jul 30, 2025 | Director | Uninformative Buy | 541.97 | $3.02M | |
| AFIBAcutus Medical | Jun 15, 2023 | Director | Uninformative Buy | ― | ― | |
| TCDAQTricida | Nov 25, 2022 | ― | Informative Sell | 2.21M | $0.00 | |
| THRDThird Harmonic Bio, Inc. | Sep 21, 2022 | ― | Uninformative Buy | ― | $31.09M | |
| RPTXRepare Therapeutics | Sep 08, 2021 | ― | Uninformative Sell | 274.79K | $254.90K | |
| ELVNEnliven Therapeutics | Jul 16, 2021 | Director, Ten Percent Owner | Informative Buy | 10.00M | $196.73M | |
| VRAYQViewray | Apr 25, 2018 | Director, Ten Percent Owner | Uninformative Buy | ― | ― | |
| LOXOLoxo Oncology | Dec 12, 2017 | ― | Informative Sell | 20.63M | $220.82M | |
| ~AMBIAmbit | May 24, 2013 | ― | Informative Buy | 233.37K | ― | |
| WWBWindward Bio Group AG | ― | Director | ― | ― |
You May Also Like
David Bonita insider profile FAQ
What is the percentage of profitable transactions made by David Bonita?
The percentage of profitable transactions made by David Bonita is 38%.
What is the average return per transaction made by David Bonita?
The average return per transaction made by David Bonita is -20.50%.
What stocks does David Bonita hold?
David Bonita holds: IMA, LOXO, VRAYQ, TCDAQ, ELVN, RPTX, AFIB, PRLD, THRD, WWB, ~AMBI stocks.
What was David Bonita’s latest transaction?
David Bonita’s latest transaction was an Informative Buy of $12.50M.
What was David Bonita's most profitable transaction?
David Bonita’s most profitable transaction was an Informative Buy of VRAYQ stock on January 20, 2017. The return on the trade was 110.20%.
What is David Bonita's role in ImageneBio?
David Bonita's role in ImageneBio is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
